Search Results
Dr. Brufsky Discusses Biosimilar Development and Approval
Dr. Brufsky on Trastuzumab Biosimilars in Breast Cancer
The Complexity of Choosing Biosimilars in Oncology
The Future Direction of Biosimilars
An Overview of Biosimilarity
Dr. Verma Discusses Biosimilars for Trastuzumab
Innovative Biosimilars Development Strategies
Dr. Lyman on Educating Physicians About Biosimilars in Oncology
Biosilimiars Are Not Generics
Pinpointing the Top Questions and Considerations about Biosimilars in Hematology/Oncology
15-years of biosimilars in Europe: What lessons can we share? - Panel 1
Module 6: Biosimilars—Advances in Research and Development